AVON, CONNECTICUT, October 15, 2014 – Ironwood Capital today announced it has closed on an investment in Pharmaceutic Litho & Label Company, in conjunction with an investment by Saugatuck Capital Company. Pharmaceutic, based in Simi Valley, CA, was founded in 1964 and is a leading printer of labels and inserts for the pharmaceutical, biotech, and medical device industries.
“Pharmaceutic maintains a unique market niche within the printing industry and an experienced and committed management team,” said Carolyn Galiette, Senior Managing Director, Ironwood Capital. “Saugatuck’s vision to grow the company is exciting and we’re pleased to be working with them on this investment,” adds Roger Roche, Senior Managing Director.
About Saugatuck Capital Company
Founded in 1982, Saugatuck Capital Company is a long-established private investment firm committed to leveraged recapitalizations and buyouts and growth equity investments in the lower, middle market. Sourcing investment opportunities through its well-established network, Saugatuck invests in service-intensive businesses demonstrating a proven ability to generate stable, growing cash flows where it has the requisite experience to drive accelerated portfolio company performance. For over three decades, the Firm has been dedicated to the philosophy of hands-on value creation in which exceptional management teams, in partnership with Saugatuck’s capital and expertise, build companies of outstanding value.
About Ironwood Capital
With over $500 million of capital under management, Ironwood Capital is a Connecticut-based private equity firm that provides non-control growth capital to middle market companies. We take a straightforward approach in providing profitable, well-managed companies with growth and transition capital coupled with strategic, operational and financial guidance. With over 25 years of middle market experience, Ironwood invests in the form of subordinated debt and preferred stock in amounts ranging from $5 million to $20 million to support business owners and financial sponsors in growth financings, full and partial recapitalizations, generational transitions and buyouts. Throughout, we seek to simplify a process that is often unnecessarily wrought with complexity and contention.